title: Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
authors.forename: M E
authors.initials: ME
authors.lastname: Griffin
authors.forename: A
authors.initials: A
authors.lastname: Feder
authors.forename: W V
authors.initials: WV
authors.lastname: Tamborlane
mesh_terms: D000273:Adipose Tissue / Q000473:pathology*; D001284:Atrophy; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D007332:Insulin Infusion Systems; D061268:Insulin Lispro; D008875:Middle Aged
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro